Literature DB >> 22639341

Diabetic cardiovascular disease: getting to the heart of the matter.

Linda R Peterson1, Clark R McKenzie, Jean E Schaffer.   

Abstract

Diabetes is a major risk factor for heart disease, and heart disease is responsible for substantial morbidity and mortality among people living with diabetes. The diabetic metabolic milieu predisposes to aggressive obstructive coronary artery disease that causes heart attacks, heart failure, and death. Furthermore, diabetes can be associated with heart failure, independent of underlying coronary artery disease, hypertension, or valve abnormalities. The pathogenesis of the vascular and myocardial complications of diabetes is, as yet, incompletely understood. Although a number of medical and surgical approaches can improve outcomes in diabetic patients with cardiovascular disease, much remains to be learned in order to optimize approaches to these critical complications.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22639341      PMCID: PMC3396765          DOI: 10.1007/s12265-012-9374-7

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  116 in total

1.  Spectrum of heart failure in older patients: results from the National Heart Failure project.

Authors:  Edward P Havranek; Frederick A Masoudi; Kelly A Westfall; Pam Wolfe; Diana L Ordin; Harlan M Krumholz
Journal:  Am Heart J       Date:  2002-03       Impact factor: 4.749

Review 2.  High-density lipoprotein--the clinical implications of recent studies.

Authors:  D J Gordon; B M Rifkind
Journal:  N Engl J Med       Date:  1989-11-09       Impact factor: 91.245

3.  Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease.

Authors:  J E Pérez; J B McGill; J V Santiago; K B Schechtman; A D Waggoner; J G Miller; B E Sobel
Journal:  J Am Coll Cardiol       Date:  1992-05       Impact factor: 24.094

4.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

5.  The final 10-year follow-up results from the BARI randomized trial.

Authors: 
Journal:  J Am Coll Cardiol       Date:  2007-04-02       Impact factor: 24.094

Review 6.  Insulin signaling in heart muscle: lessons from genetically engineered mouse models.

Authors:  E Dale Abel
Journal:  Curr Hypertens Rep       Date:  2004-12       Impact factor: 5.369

7.  Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Lars H Lindholm; Hans Ibsen; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristiansson; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Peter Aurup; Jonathan Edelman; Steven Snapinn
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

8.  The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group.

Authors:  P H Stone; J E Muller; T Hartwell; B J York; J D Rutherford; C B Parker; Z G Turi; H W Strauss; J T Willerson; T Robertson
Journal:  J Am Coll Cardiol       Date:  1989-07       Impact factor: 24.094

9.  Silent myocardial ischemia: role of subclinical neuropathy in patients with and without diabetes.

Authors:  B Marchant; V Umachandran; R Stevenson; P G Kopelman; A D Timmis
Journal:  J Am Coll Cardiol       Date:  1993-11-01       Impact factor: 24.094

10.  The relationship of fasting serum radioimmune insulin levels to incident coronary heart disease in an insulin-treated diabetic cohort.

Authors:  Richard A Kronmal; Joshua I Barzilay; Russell P Tracy; Peter J Savage; Trevor J Orchard; Gregory L Burke
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

View more
  10 in total

1.  Impact of diabetes mellitus on the clinical response to cardiac resynchronization therapy in elderly people.

Authors:  Celestino Sardu; Raffaele Marfella; Gaetano Santulli
Journal:  J Cardiovasc Transl Res       Date:  2014-02-06       Impact factor: 4.132

2.  A Diet Rich in Medium-Chain Fatty Acids Improves Systolic Function and Alters the Lipidomic Profile in Patients With Type 2 Diabetes: A Pilot Study.

Authors:  Sophia Airhart; W Todd Cade; Hui Jiang; Andrew R Coggan; Susan B Racette; Kevin Korenblat; Catherine Anderson Spearie; Suzanne Waller; Robert O'Connor; Adil Bashir; Daniel S Ory; Jean E Schaffer; Eric Novak; Marsha Farmer; Alan D Waggoner; Víctor G Dávila-Román; Cylen Javidan-Nejad; Linda R Peterson
Journal:  J Clin Endocrinol Metab       Date:  2015-12-10       Impact factor: 5.958

3.  Mitigation of diabetes-related complications in implanted collagen and elastin scaffolds using matrix-binding polyphenol.

Authors:  James P Chow; Dan T Simionescu; Harleigh Warner; Bo Wang; Sourav S Patnaik; Jun Liao; Agneta Simionescu
Journal:  Biomaterials       Date:  2012-10-24       Impact factor: 12.479

4.  Improvement of cardiac ventricular function by magnesium treatment in chronic streptozotocin-induced diabetic rat heart.

Authors:  Hamida Aboalgasm; Morea Petersen; Asfree Gwanyanya
Journal:  Cardiovasc J Afr       Date:  2020-12-10       Impact factor: 1.167

5.  Both high and low HbA1c predict incident heart failure in type 2 diabetes mellitus.

Authors:  Helen M Parry; Harshal Deshmukh; Daniel Levin; Natalie Van Zuydam; Douglas H J Elder; Andrew D Morris; Allan D Struthers; Colin N A Palmer; Alex S F Doney; Chim C Lang
Journal:  Circ Heart Fail       Date:  2015-01-05       Impact factor: 8.790

6.  Diabetic complications: current challenges and opportunities.

Authors:  Helen D Nickerson; Sanjoy Dutta
Journal:  J Cardiovasc Transl Res       Date:  2012-06-30       Impact factor: 4.132

7.  Role of PET-CT in the assessment of myocardial viability in patients with left ventricular dysfunction.

Authors:  Madhur Kumar Srivatsava; M Indirani; I Sathyamurthy; G Sengottuvelu; Avani S Jain; S Shelley
Journal:  Indian Heart J       Date:  2016-01-11

8.  Contemporary risk estimates of three HbA1c variables in relation to heart failure following diagnosis of type 2 diabetes.

Authors:  Stanko Skrtic; Claudia Cabrera; Marita Olsson; Volker Schnecke; Marcus Lind
Journal:  Heart       Date:  2016-09-19       Impact factor: 5.994

Review 9.  Myocardial Adaptation in Pseudohypoxia: Signaling and Regulation of mPTP via Mitochondrial Connexin 43 and Cardiolipin.

Authors:  Miroslav Ferko; Natália Andelová; Barbara Szeiffová Bačová; Magdaléna Jašová
Journal:  Cells       Date:  2019-11-17       Impact factor: 6.600

Review 10.  Cardiac Resynchronization Therapy Outcomes in Type 2 Diabetic Patients: Role of MicroRNA Changes.

Authors:  Celestino Sardu; Michelangela Barbieri; Maria Rosaria Rizzo; Pasquale Paolisso; Giuseppe Paolisso; Raffaele Marfella
Journal:  J Diabetes Res       Date:  2015-11-09       Impact factor: 4.011

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.